Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives. #Cimzia #CrohnsDisease #Entyvio #biologics biosimilars #certolizumab #golimumab #infliximab #interleukin #natalizumab #ustekinumab #vedolizumab https
Biologics and biosimilars in inflammatory bowel disease https://t.co/8d8fbCjPK5 Epidemiology/Trends of hepatocellular carcinoma https://t.co/LYFoF7364K Euglycemic diabetic ketoacidosis a dilemma https://t.co/iv9vY26eX9 Fecal microbiota transplant–in IBD ht
Biologics and biosimilars in inflammatory bowel disease https://t.co/DFR3MO58V0 Epidemiology/Trends of hepatocellular carcinoma https://t.co/aHm5GJQ8JY Euglycemic diabetic ketoacidosis a dilemma https://t.co/oyFMc9c26Z Fecal microbiota transplant–in IBD ht
Biologics and biosimilars in inflammatory bowel disease https://t.co/bDMD9dIcIT Epidemiology/Trends of hepatocellular carcinoma https://t.co/lH05FCOyg6 Euglycemic diabetic ketoacidosis a dilemma https://t.co/qsbie2f4fE Fecal microbiota transplant–in IBD ht
Biologics and biosimilars in inflammatory bowel disease https://t.co/1qmyz7FXg8 Epidemiology/Trends of hepatocellular carcinoma https://t.co/mgcbTTYGpZ Euglycemic diabetic ketoacidosis a dilemma https://t.co/3OO3FKNoI3 Fecal microbiota transplant–in IBD ht
RT @rawlapr: See my latest publication https://t.co/rTc7NtcjtK